Imagine a world without disease.
A world where we join forces to accelerate the development of advanced medicines and ensure access to cures for all patients, everywhere.
Impact the lives of all patients needing a cure.
Make a donation.
Fuel innovative gene & cell therapy advancement and help us overcome the obstacles to delivering cures.
Join our community.
Learn how advanced medicines can cure, network with members, and collaborate on cutting-edge initiatives.
people living with HIV worldwide, including 1.8 million children.
new cancer cases in 2018 with over 9.5 million deaths worldwide.
genetic disorders exist, many
of which are fatal or debilitating.
is the price for a one-time advanced therapy, not including hospital costs.
Such pricing is not sustainable in developed countries, let alone the developing world, leaving many without access to potential cures. We can do better.
Access to medicines that can cure is a basic human right, no matter who you are.
At Caring Cross, we believe that every person should be able to access advanced medicines at an affordable cost.
We enable access by building a community of healthcare professionals, scientists and engineers, community advocates and business leaders that collaborate to develop and deliver curative therapies for infectious diseases like HIV, cancer, genetic diseases, and other serious disorders.
Here’s how we do it:
We hold educational events to share the latest advanced medicinal innovations via talks, tutorials, and panel discussions.
Our passionate community uses science & technology to develop and implement affordable curative medicines for all.
We are developing curative medicines, that upon clinical success, will be made available to all who need them affordably and sustainably.
We collaborate with organizations and create new initiatives to encourage affordable access of curative medicines for underserved communities worldwide.
We collaborate with companies and start new ones, developing curative medicines and technologies under agreements enabling affordable access.
Thank you for registering! Please check your email for confirmation, and add this event to your calendar. Double-check Spam or Promotions just in case it landed there.
Access to a webinar link will be provided the day of this event.
While you’re waiting? Follow us on Twitter for updates.
Kevin Curran, PhD
Focus on AAV Gene Therapy
Dr. John Tisdale / NIH
Toward Molecular Cures for The First Molecular Disease, Cell and Gene Therapies for Sickle Cell Disease
Kevin Curran, PhD